DEF: National Healthcare Properties Reports Strong 2025, Sets 2026 AGM

National Healthcare Properties, Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on May 15, 2026, where shareholders will vote on director elections, auditor ratification, and executive compensation, following a year of strong financial performance and governance enhancements.

Summary

• The 2026 Annual Meeting of Stockholders will be held virtually on May 15, 2026, at 12:00 p.m. Eastern Time, with a record date of February 26, 2026.
• Stockholders will vote on the election of six directors, ratification of PricewaterhouseCoopers LLP (PwC) as the independent registered public accounting firm for 2026, a non-binding advisory resolution on named executive officer compensation (Say on Pay), and a non-binding advisory resolution on the frequency of the Say on Pay vote (Say on Frequency), with the Board recommending an annual vote.
• The company completed the internalization of its advisory and property management functions on September 27, 2024, eliminating approximately $22 million in external management fees for 2023.
• A one-for-four reverse stock split was effected on September 30, 2024, and the company's name changed from Healthcare Trust, Inc. to National Healthcare Properties, Inc.
• Corporate governance was significantly enhanced by de-classifying the Board, with all directors standing for annual elections starting with the 2026 Annual Meeting, and terminating the stockholder rights plan (poison pill).
• Scott W. Humphrey was appointed as an independent director and chair of the audit committee in January 2026, and Heidrick & Struggles, Inc. was engaged in March 2026 to identify additional non-executive and independent directors.
• As of December 31, 2025, the company's portfolio had over $2 billion in gross real estate value, comprising 37 senior housing communities (3,615 units) and 130 outpatient medical facilities (approximately 3.7 million square feet) across 29 states.
• For 2025, Nareit defined Funds From Operations (FFO) per share increased 116.7% year-over-year, and Normalized FFO per share increased 162.7% year-over-year.
• Full year 2025 portfolio same store cash net operating income (NOI) growth was 9.0% year-over-year, with the senior housing operating portfolio segment growing 21.8% and outpatient medical facilities segment growing 2.9%.
• The company completed $202.5 million in dispositions of 25 non-core assets in 2025, reduced net leverage by 1.1x from year-end 2024 to year-end 2025, and repurchased $8.6 million in preferred stock at an effective yield of 11.5%.
• The $30.3 million unsecured promissory note issued as part of the internalization was fully repaid in January 2025.
• CEO Michael Anderson's 2025 total compensation was $6,490,000, resulting in a 42:1 pay ratio compared to the median employee's $154,192 annual total compensation.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive filing, reflecting strong financial performance, significant governance enhancements, and strategic capital management following the internalization. The substantial growth in FFO and NOI, coupled with leverage reduction and preferred stock repurchases, indicates robust operational and financial health.

Positives

• Elimination of approximately $22 million in external management fees for 2023 following the internalization of management functions.
• Significant enhancement of corporate governance standards, including Board de-classification and termination of the stockholder rights plan (poison pill).
• Appointment of Scott W. Humphrey as an independent director and chair of the audit committee in January 2026.
• Strong financial performance in 2025, with Nareit defined FFO per share increasing 116.7% year-over-year and Normalized FFO per share increasing 162.7% year-over-year.
• Robust organic growth demonstrated by a 9.0% year-over-year portfolio same store cash NOI growth, including 21.8% in the senior housing operating portfolio segment.
• Strengthened balance sheet through $202.5 million in non-core asset dispositions and a 1.1x reduction in net leverage from year-end 2024 to year-end 2025.
• Opportunistic repurchase of $8.6 million in preferred stock at an attractive effective yield of 11.5%.
• Full repayment of the $30.3 million unsecured promissory note in January 2025.
• CEO Michael Anderson's individual performance for 2025 was scored at maximum, reflecting exceptional achievement of strategic and financial goals.

Negatives

• Reported a Net Loss Attributable to Common Stockholders of $(71,067) thousand for 2025, following losses of $(203,495) thousand in 2024 and $(86,097) thousand in 2023.
• The company paid an internalization fee of $98.2 million and additional fees totaling $8.4 million to the former Advisor and its parent company in 2024.
• The company's common stock is not listed on Nasdaq, which may impact liquidity and broader market access.

Risks

• Risks associated with the methodologies and assumptions used to determine, and the limitations of, the Estimated Per-Share NAV.
• Cybersecurity risks and other information technology risks are part of the Board's risk oversight function.
• Potential impact of Section 162(m) of the Internal Revenue Code on tax deductions for executive compensation, though mitigated by the company's REIT status.
• Risks arising from the company's compensation policies and practices for employees, though the CCG Committee determined these are not reasonably likely to have a material adverse effect.

Future Outlook

The company expects to approve 2026 Long-Term Incentive Program (LTIP) Grants with a balanced mix of time-based and performance-based equity awards. Management is making significant progress towards a potential listing of the company's common stock and a potential equity offering, as well as building an acquisition pipeline and underwriting process.

Management Comments

• Michael Anderson, CEO and President: "I am pleased to invite you to the 2026 Annual Meeting of Stockholders... Your vote is very important. Please respond as soon as possible to help us avoid potential delays and additional expenses to solicit votes. On behalf of the Board of Directors, we appreciate your support."
• The Board unanimously recommends voting FOR the election of each nominee, FOR a frequency of one year with respect to the Say on Frequency proposal, and FOR each other proposal.
• The Compensation and Corporate Governance Committee (CCG Committee) determined that the risks arising from the company's compensation policies and practices are not reasonably likely to have a material adverse effect on the company.
• The CCG Committee may, in its judgment, authorize compensation payments subject to deduction limitations under Section 162(m) of the Code when it believes that doing so is appropriate to attract and retain executive talent.

Industry Context

StockSavvy.ai notes that National Healthcare Properties operates as a self-managed REIT focused on senior housing and healthcare real estate, strategically positioned to capitalize on favorable demographic trends of a growing elderly U.S. population. The company's internalization of management functions and focus on governance enhancements align with broader industry trends towards greater transparency and shareholder alignment, particularly for REITs. The strong organic growth in its senior housing portfolio (21.8% YOY) suggests effective management in a sector facing demographic tailwinds, while the outpatient medical facilities also show steady growth.

Comparison to Industry Standards

• The company engaged Ferguson Partners Consulting, a 'leading compensation consultant that specialized in the REIT industry,' and established a new executive compensation peer group, indicating an effort to align compensation practices with industry best practices.
• The 2025 FFO per share growth of 116.7% and Normalized FFO per share growth of 162.7% year-over-year are exceptionally strong, likely outperforming many peers in the healthcare REIT sector, which typically experience more moderate FFO growth.
• The 9.0% portfolio same store cash NOI growth, particularly the 21.8% in senior housing, indicates robust operational performance that could be considered strong compared to the average for healthcare REITs, especially those with significant senior housing exposure, which have faced varying degrees of recovery post-pandemic.
• The reduction in net leverage by 1.1x from year-end 2024 to year-end 2025 demonstrates a commitment to balance sheet strength, which is a positive signal in the current interest rate environment and compares favorably to companies with higher or increasing leverage.
• The repurchase of $8.6 million in preferred stock at an 11.5% effective yield suggests opportunistic capital management, potentially indicating a belief that the company's common equity is undervalued or that this is an efficient use of capital compared to other investment opportunities.
• The peer group listed includes direct comparables in the healthcare REIT space such as American Healthcare REIT, CareTrust REIT, Global Medical REIT Inc., LTC Properties, Inc., National Health Investors, Inc., and Sabra Health Care REIT, Inc., suggesting the company benchmarks its performance against established industry players.

Management Changes

Corporate Governance

Legal Proceedings

• No directors or named executive officers are party to any material legal proceedings.

Related Party Transactions

• Internalization Agreement (August 6, 2024): The former Advisor received an internalization fee of $98.2 million, and the Advisor Parent received an asset management fee of $5.5 million and a property management fee of $2.9 million. An unsecured promissory note of $30.3 million was issued to the Advisor Parent, which was fully repaid in January 2025.
• Healthcare Trust Special Limited Partner, LLC (an affiliate of the former Advisor) owned 2,718 shares of Common Stock and 90 partnership units in the operating partnership.
• Transition Services Arrangement: The Advisor Parent provided transitional services for up to nine months post-internalization, for which the company reimbursed approximately $0.1 million in 2024 and $0.3 million in 2025. This arrangement expired in June 2025.
• Indemnification agreements have been entered into with each executive officer and director, providing for indemnification to the maximum extent permitted by Maryland law and advancement of expenses.
• Edward M. Weil, Jr., a director, holds a non-controlling interest in the parent of AR Global (the former Advisor's controlling entity), but disclaims beneficial ownership of AR Global's securities in the company.

Stakeholder Impact

• Shareholders: Benefit from enhanced corporate governance, elimination of external management fees, strong financial performance (FFO, NOI growth, leverage reduction), and potential for future equity offering and common stock listing. They will also vote on key corporate matters.
• Employees: Benefit from the internalization creating a self-managed structure with dedicated employees and an executive compensation program designed to attract, retain, and motivate.
• Customers/Tenants: Benefit from continued operational management, NOI margin expansion in senior housing, internalization of property management for outpatient medical facilities, and effective management of relationships with major tenants and senior housing operators.
• Creditors: Benefit from reduced net leverage, the full repayment of the $30.3 million promissory note, and the establishment of a new $550 million senior unsecured credit facility, indicating improved financial stability.

Next Steps

• Hold the 2026 Annual Meeting of Stockholders on May 15, 2026, for shareholder votes on key proposals.
• Engage Heidrick & Struggles, Inc. to assist in identifying and selecting potential additional non-executive and independent directors for the Board.
• The Compensation and Corporate Governance Committee (CCG Committee) expects to approve 2026 Long-Term Incentive Program (LTIP) Grants.
• Future information regarding the 2026 Annual Incentive Program (AIP) and LTIP Grants will be provided in the 2027 Annual Meeting proxy statement.
• Stockholder proposals for the 2027 Annual Meeting under Rule 14a-8 are due by December 1, 2026.
• Stockholder nominations for directors or other business proposals under the Bylaws for the 2027 Annual Meeting are due between November 1, 2026, and December 1, 2026.
• Stockholders intending to solicit proxies for director nominees for the 2027 Annual Meeting must provide notice by March 16, 2027, under Rule 14a-19(b).

Key Dates

Recommendation

The filing reveals exceptionally strong financial performance in 2025, with FFO per share up 116.7% and Normalized FFO per share up 162.7% year-over-year, alongside robust organic NOI growth (9.0% overall, 21.8% in senior housing). The company has significantly strengthened its balance sheet through asset dispositions and leverage reduction, and opportunistically repurchased preferred stock. Furthermore, the substantial corporate governance enhancements, including Board de-classification and the termination of the poison pill, demonstrate a strong commitment to shareholder-friendly practices. While the company reported a net loss, the operational and FFO metrics are highly indicative of underlying business strength and future potential, especially with the stated progress towards a common stock listing and potential equity offering. These factors collectively suggest a strong investment opportunity.

Keywords

Healthcare REIT, Real Estate Investment Trust, Proxy Statement, Corporate Governance, Executive Compensation, Annual Meeting, Shareholder Vote, Internalization, Senior Housing, Outpatient Medical Facilities, Financial Performance, FFO Growth, NOI Growth, Leverage Reduction, Board of Directors, Audit Committee, Compensation Committee, Risk Management, Stock Ownership Guidelines